EI
DCPH

Ellevest Inc’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Ellevest Inc’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-161
Closed -$2.49K – 1757
2023
Q1 		$2.49K Sell
161
-38
-19% -$634 ﹤0.01% 1403
2022
Q4 		$3.26K Sell
199
-7
-3% -$114 ﹤0.01% 1292
2022
Q3 		$4K Buy
206
+86
+72% +$1.35K ﹤0.01% 1248
2022
Q2 		$2K Buy
+120
New +$1.32K ﹤0.01% 1188

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ellevest Inc's DCPH Position: Q2 2023 in Review

Ellevest Inc sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2023, closing a stake of 161 shares — an estimated $2.49K sold.

Ellevest Inc first reported a position in DCPH in Q2 2022 and held it in 4 quarters. The position peaked at $4K in Q3 2022. 145 funds tracked by Wall St. Rank hold DCPH as of Q2 2023.

  • Ellevest Inc reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 161 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $2.49K.
  • Ellevest Inc first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Ellevest Inc's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q3 2022.
  • 145 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.